NM_031448.6:c.391A>G
Variant summary
Our verdict is Benign. Variant got -7 ACMG points: 2P and 9B. PM1BP4_StrongBS1_SupportingBS2
The NM_031448.6(C19orf12):āc.391A>Gā(p.Lys131Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00158 in 1,613,932 control chromosomes in the GnomAD database, including 18 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_031448.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -7 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00122 AC: 186AN: 152142Hom.: 3 Cov.: 32
GnomAD3 exomes AF: 0.00229 AC: 573AN: 250744Hom.: 3 AF XY: 0.00271 AC XY: 368AN XY: 135794
GnomAD4 exome AF: 0.00162 AC: 2367AN: 1461672Hom.: 15 Cov.: 30 AF XY: 0.00190 AC XY: 1379AN XY: 727130
GnomAD4 genome AF: 0.00123 AC: 187AN: 152260Hom.: 3 Cov.: 32 AF XY: 0.00130 AC XY: 97AN XY: 74444
ClinVar
Submissions by phenotype
not provided Benign:5
- -
C19orf12: PM3, PM2:Supporting, BP4, BS2 -
- -
- -
This variant is associated with the following publications: (PMID: 30088953, 21981780, 25592411) -
Neurodegeneration with brain iron accumulation 4 Pathogenic:2Uncertain:2
- -
Variant confirmed as disease-causing by referring clinical team -
- -
- -
Hereditary spastic paraplegia 43 Benign:2
- -
- -
Dystonic disorder;C0040822:Tremor;C0234985:Mental deterioration;C0241688:Peripheral visual field loss;C4024790:Adult-onset night blindness Pathogenic:1
- -
Hereditary spastic paraplegia Uncertain:1
- -
Hereditary spastic paraplegia 5A Uncertain:1
- -
not specified Benign:1
Variant summary: C19orf12 c.391A>G (p.Lys131Glu) results in a conservative amino acid change in the encoded protein sequence. Four of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 0.0023 in 250744 control chromosomes, predominantly at a frequency of 0.0096 within the South Asian subpopulation in the gnomAD database, including 3 homozygotes. The observed variant frequency within South Asian control individuals in the gnomAD database is approximately 16 fold of the estimated maximal expected allele frequency for a pathogenic variant in C19orf12 causing Neurodegeneration With Brain Iron Accumulation phenotype (0.0006), strongly suggesting that the variant is a benign polymorphism found primarily in populations of South Asian origin. To our knowledge, no experimental evidence demonstrating its impact on protein function have been reported. Eight submitters have cited clinical-significance assessments for this variant to ClinVar after 2014. Multiple submitters reported the variant with conflicting assessments: benign (n=1), likely benign (n=3), uncertain significance (n=3) and pathogenic (n=1). Based on the evidence outlined above, the variant was classified as benign. -
Hereditary spastic paraplegia 43;C3280371:Neurodegeneration with brain iron accumulation 4 Other:1
GenomeConnect assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. GenomeConnect staff make no attempt to reinterpret the clinical significance of the variant. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at